Suppr超能文献

氯喹视网膜病变中色觉缺陷的检测

Detection of color vision defects in chloroquine retinopathy.

作者信息

Vu B L, Easterbrook M, Hovis J K

机构信息

Department of Ophthalmology, University of Toronto, Canada.

出版信息

Ophthalmology. 1999 Sep;106(9):1799-803; discussion 1804. doi: 10.1016/S0161-6420(99)90338-X.

Abstract

OBJECTIVE

The effect of chloroquine toxicity on color vision is unclear. The authors identified the color defects seen in chloroquine retinopathy and determined the sensitivity and specificity of clinical color vision tests for detecting the presence of previously diagnosed chloroquine retinopathy.

DESIGN

Case-control study.

PARTICIPANTS

Chloroquine retinopathy was defined using previously published criteria. Data from 30 patients with retinopathy and 25 patients using chloroquine but with no evidence of retinal toxicity were collected.

METHODS

All patients were tested with the following six clinical color vision tests: Ishihara, Farnsworth D-15, and Adams Desaturated-15 (Dsat-15), City University 2nd Edition (CU), Standard Pseudoisochromatic Plates Part 2 (SPP-2), and American Optical Hardy Rand Rittler (AO HRR).

MAIN OUTCOME MEASURES

The number of failures was determined for each test. The types of color vision defects were classified as blue-yellow (BY), red-green (RG), or mixed RG and BY (mixed).

RESULTS

Of the 30 patients with retinopathy, 28 (93.3%) of 30 patients failed at least 1 color vision test, demonstrating predominantly mixed defects. Five (25%) of 25 of the control subjects failed at least 1 test, and these defects were predominantly BY. The sensitivity and specificity of the tests are as follows: SPP-2 (93.3%, 88%), AO HRR (76.7%, 88%), Ishihara (43.3%, 96%), Dsat-15 (33.3%, 84%), D-15 (16.7%, 96%), and CU (20%, 92%).

CONCLUSIONS

Color vision can be affected by chloroquine and should be tested routinely with a color vision test designed to detect both mild BY and protan RG defects to maximize sensitivity for toxicity. The SPP-2 and AO HRR are two tests that meet these criteria. The Ishihara has a low sensitivity, as do the D-15 tests and CU. All of the tests have similar specificity for chloroquine toxicity. If color vision defects are detected in patients at risk of developing chloroquine retinopathy, additional testing is indicated to rule out toxicity.

摘要

目的

氯喹毒性对色觉的影响尚不清楚。作者确定了氯喹视网膜病变中所见的颜色缺陷,并确定了临床色觉测试对检测先前诊断的氯喹视网膜病变的敏感性和特异性。

设计

病例对照研究。

参与者

氯喹视网膜病变采用先前公布的标准进行定义。收集了30例视网膜病变患者和25例使用氯喹但无视网膜毒性证据患者的数据。

方法

所有患者均接受以下六种临床色觉测试:石原氏色盲测试、法恩斯沃思D-15测试、亚当斯去饱和-15测试(Dsat-15)、城市大学第二版测试(CU)、标准假同色图第二部分测试(SPP-2)以及美国光学哈迪·兰德·里特勒测试(AO HRR)。

主要观察指标

确定每种测试未通过的人数。色觉缺陷类型分为蓝黄色(BY)、红绿色(RG)或RG和BY混合(混合)。

结果

在30例视网膜病变患者中,30例中有28例(93.3%)至少一项色觉测试未通过,主要表现为混合缺陷。25例对照受试者中有5例(25%)至少一项测试未通过,这些缺陷主要为BY。各项测试的敏感性和特异性如下:SPP-2(93.3%,88%)、AO HRR(76.7%,88%)、石原氏色盲测试(43.3%,96%)、Dsat-15(33.3%,84%)、D-15(16.7%,96%)以及CU(20%,92%)。

结论

氯喹可影响色觉,应使用旨在检测轻度BY和红色盲RG缺陷的色觉测试进行常规检测,以最大限度提高对毒性的敏感性。SPP-2和AO HRR是符合这些标准的两项测试。石原氏色盲测试以及D-15测试和CU的敏感性较低。所有测试对氯喹毒性的特异性相似。如果在有发生氯喹视网膜病变风险的患者中检测出色觉缺陷,则需进行额外检测以排除毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验